Detection of circulating cell‐free mRNA serves as noninvasive tools for cancer diagnosis. As an oncofetal protein, HMGA2 (high mobility group AT‐hook 2) is upregulated in colorectal cancer (CRC) tissues. However,… Click to show full abstract
Detection of circulating cell‐free mRNA serves as noninvasive tools for cancer diagnosis. As an oncofetal protein, HMGA2 (high mobility group AT‐hook 2) is upregulated in colorectal cancer (CRC) tissues. However, it is not clear whether the increased levels of circulating cell‐free HMGA2 mRNA functions as potential biomarkers for improved diagnosis of CRC.
               
Click one of the above tabs to view related content.